Global Health Limited

NSE: MEDANTAHealthcare

Global Health Limited Share Price & Analysis

₹1283.00+1.78%Updated 28 Oct 2026, 03:30 pm IST
LTP
₹1283.00+1.78%
Open
₹1252.00
High
₹1294.40
Low
₹1245.40
Close
₹1283.00
52W High
₹1544.00
52W Low
₹955.00
Volume
130K
Lot Size
1
Sector
Healthcare
Market Cap
₹32K Cr
Face Value
₹2
Large CapNIFTY 500Nifty Midcap 150

Price Chart

Candle
Range

Fundamentals

P/E
55.60
Sector P/E
50.20
P/B
—
EPS
₹20.69
ROE
15.20%
ROCE
17.40%
D/E Ratio
0.30
Div Yield
0.04%
Book Value
₹147.00

Strengths

  • Strong return on equity (ROE 15.2%)
  • Efficient capital deployment (ROCE 17.4%)
  • Low debt relative to equity (D/E 0.3x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,758
    ₹4.2L Cr33.25.051620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,559
    ₹2.4L Cr79.815.1516.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,557
    ₹1.7L Cr79.39.4327.415.20.77
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,176
    ₹1.1L Cr23.14.3721.221.10.38
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,137
    ₹1.1L Cr52.812.3521.217.40.88
    CIPLA
    Cipla Limited
    ₹1,366
    ₹1.1L Cr30.23.2111.615.50.01
    LAURUSLABS
    Laurus Labs Limited
    ₹2,182
    ₹1.1L Cr97.422.2218.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    MEDANTA · as of Mar 2026

    Promoters33.03%
    FII11.76%0.72pp
    DII11.93%1.42pp
    Public43.28%0.70pp
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters33.05%33.04%33.04%33.04%33.03%33.03%
    FII11.36%12.10%12.94%12.21%12.48%11.76%
    DII11.15%10.25%10.57%11.11%10.51%11.93%
    Public44.45%44.60%43.44%43.64%43.98%43.28%

    Corporate Events

    To consider and approve the financial results for the period ended September 30, 2026

    Results2 Nov 2026

    Dividend - Re 0.50 Per Share

    Dividend13 Aug 2026

    To consider and approve the financial results for the period ended Jun 30, 2026

    Results29 Jul 2026

    To consider and approve the financial results for the quarter and year ended March 31, 2026 and recommendation of final dividend, if any subject to shareholders approval.

    Dividend13 May 2026

    Dividend - Re 0.50 Per Share

    Dividend21 Aug 2025

    Latest News

    All news

    STL Global reports Q1FY26 financial results

    *STL Global reports Q1FY26 financial results*. The company has submitted its financial results for the quarter ended June 30, 2026. Key performance numbers and guidance will influence near-term trading sentiment. Investors await details on revenue, profit margins, and order book. 📊 *STOCKS:* $STL | 🏢 *SECTOR:* CapitalMarkets | #HIGHIMPACT #Earnings

    NSE Filing13 Aug
    High Impact

    India's services growth hits six-month high on strong domestic demand

    *India's services growth hits six-month high on strong domestic demand.* The S&P Global Services PMI rose to **61.0** in May, the highest since November, driven by robust domestic demand. New orders surged with a sharp increase in business confidence. Output and employment expanded at faster rates. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #HIGHIMPACT #PMI

    The Economic Times3 Jun
    High Impact

    Medanta to acquire 10,560 sqm land in Ghaziabad for expansion

    *Medanta to acquire 10,560 sqm land in Ghaziabad for expansion.* The acquisition supports its plan to expand healthcare services in Uttar Pradesh. The land parcel is strategically located to enhance patient access and operational capacity. This move signals long-term growth focus in North India. 📊 *STOCKS:* MEDANTA | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Expansion

    NSE Filing29 Sept
    Medium Impact

    Mastek partners with Innovaccer for AI healthcare push

    *Mastek partners with Innovaccer for AI healthcare push.* The collaboration aims to accelerate AI-driven solutions in healthcare. While financial details weren’t disclosed, the strategic move enhances Mastek’s footprint in the global health tech space. **No immediate revenue impact** expected in FY25. 📊 *STOCKS:* $MASTEK | 🏢 *SECTOR:* IT | #MEDIUMIMPACT #Partnership

    NSE Filing3 Aug
    Medium Impact

    Avio appoints Sandeep Pandya to lead global healthcare expansion

    *Avio appoints Sandeep Pandya to lead global healthcare expansion.* The move signals a strategic push into international diagnostics markets. Pandya brings **20+ years** of global healthcare experience. This leadership hire aims to scale the company’s footprint in emerging regions. 📊 *STOCKS:* AVIO | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Leadership

    NSE Filing17 Jun
    Medium Impact

    India services growth hits 3-month high but quarterly low since 2022

    *India services growth hits 3-month high but quarterly low since 2022*. The S&P Global Services PMI rose to **55.1** in March, up from **53.8** in February, signaling a rebound in expansion. However, the average quarterly reading was the weakest since 2022, indicating uneven recovery. Growth momentum remains fragile despite recent improvement. 📊 *STOCKS:* | 🏢 *SECTOR:* Macro | #MEDIUMIMPACT #PMI

    Reuters6 Oct
    Medium Impact

    Global Health receives ESG rating from Crisil

    *Global Health receives ESG rating from Crisil* — Crisil ESG Ratings & Analytics Limited has assigned an ESG rating to Global Health Limited under SEBI's disclosure norms. The rating reflects the company’s environmental, social, and governance practices. This is a compliance-related disclosure with no immediate financial impact. 📊 *STOCKS:* $MEDANTA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ESG

    NSE Filing5 Oct
    Low Impact

    STL Global to hold shareholder meeting on Sep 30, 2026

    *STL Global to hold shareholder meeting on Sep 30, 2026.* The meeting is scheduled for **September 30, 2026**, as per an NSE filing. No specific agenda details were disclosed. This is a routine corporate event with no immediate financial impact. 📊 *STOCKS:* $STL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ShareholderMeeting

    NSE Filing30 Sept
    Low Impact

    Global Health Limited issues general updates

    *Global Health Limited issues general updates.* The company filed a routine corporate update with the NSE. No specific financial or operational details were disclosed. Such filings typically contain administrative or procedural information. 📊 *STOCKS:* $GLOBALHEALTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporate

    NSE Filing28 Sept
    Low Impact

    Global Health to host investor meet for updates

    *Global Health to host investor meet for updates.* The company will conduct an analyst and institutional investor meet to discuss business developments. Specific date and agenda details will be shared via official channels. Investors await strategic insights and operational updates. 📊 *STOCKS:* MEDANTA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorMeet

    NSE Filing17 Sept
    Low Impact

    Financials

    Quarterly Results

    MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Revenue
    ₹1.1K Cr
    2.0%
    ₹1.1K Cr
    6.6%
    ₹1.0K Cr
    10.7%
    ₹931 Cr
    1.3%
    ₹943 Cr
    1.5%
    ₹957 Cr
    11.1%
    ₹861 Cr
    6.4%
    ₹809 Cr
    Op. Profit
    ₹217 Cr
    6.1%
    ₹231 Cr
    6.5%
    ₹247 Cr
    9.8%
    ₹225 Cr
    5.5%
    ₹238 Cr
    4.4%
    ₹228 Cr
    22.6%
    ₹186 Cr
    3.9%
    ₹179 Cr
    OPM
    19.0%
    9.5%
    21.0%
    12.5%
    24.0%
    0.0%
    24.0%
    4.0%
    25.0%
    4.2%
    24.0%
    9.1%
    22.0%
    0.0%
    22.0%
    Net Profit
    ₹95 Cr
    39.9%
    ₹158 Cr
    0.6%
    ₹159 Cr
    57.4%
    ₹101 Cr
    29.4%
    ₹143 Cr
    9.2%
    ₹131 Cr
    23.6%
    ₹106 Cr
    16.5%
    ₹127 Cr
    EPS (₹)
    3.54
    39.9%
    5.89
    0.5%
    5.92
    56.6%
    3.78
    28.9%
    5.32
    9.2%
    4.87
    23.0%
    3.96
    16.5%
    4.74

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
    Revenue
    ₹4.4K Cr
    19.4%
    ₹3.7K Cr
    12.7%
    ₹3.3K Cr
    20.8%
    ₹2.7K Cr
    25.1%
    ₹2.2K Cr
    49.8%
    ₹1.4K Cr
    3.5%
    ₹1.5K Cr
    3.0%
    ₹1.5K Cr
    8.4%
    ₹1.3K Cr
    2.8%
    ₹1.4K Cr
    Expenses
    ₹3.5K Cr
    24.0%
    ₹2.8K Cr
    13.8%
    ₹2.5K Cr
    19.0%
    ₹2.1K Cr
    21.3%
    ₹1.7K Cr
    36.7%
    ₹1.3K Cr
    4.5%
    ₹1.3K Cr
    2.0%
    ₹1.3K Cr
    5.3%
    ₹1.2K Cr
    12.7%
    ₹1.1K Cr
    Op. Profit
    ₹930 Cr
    5.0%
    ₹886 Cr
    9.5%
    ₹809 Cr
    27.0%
    ₹637 Cr
    39.1%
    ₹458 Cr
    132.5%
    ₹197 Cr
    2.6%
    ₹192 Cr
    11.6%
    ₹172 Cr
    37.6%
    ₹125 Cr
    58.5%
    ₹301 Cr
    OPM
    21.0%
    12.5%
    24.0%
    4.0%
    25.0%
    4.2%
    24.0%
    14.3%
    21.0%
    50.0%
    14.0%
    7.7%
    13.0%
    8.3%
    12.0%
    33.3%
    9.0%
    59.1%
    22.0%
    Other Income
    ₹98 Cr
    237.9%
    ₹29 Cr
    61.3%
    ₹75 Cr
    53.1%
    ₹49 Cr
    25.6%
    ₹39 Cr
    25.8%
    ₹31 Cr
    29.5%
    ₹44 Cr
    12.0%
    ₹50 Cr
    2.0%
    ₹49 Cr
    8.9%
    ₹45 Cr
    Interest
    ₹90 Cr
    21.6%
    ₹74 Cr
    11.9%
    ₹84 Cr
    2.3%
    ₹86 Cr
    0.0%
    ₹86 Cr
    17.8%
    ₹73 Cr
    28.1%
    ₹57 Cr
    50.0%
    ₹38 Cr
    35.7%
    ₹28 Cr
    100.0%
    ₹14 Cr
    Depreciation
    ₹223 Cr
    14.9%
    ₹194 Cr
    12.1%
    ₹173 Cr
    15.3%
    ₹150 Cr
    15.4%
    ₹130 Cr
    5.7%
    ₹123 Cr
    7.0%
    ₹115 Cr
    12.7%
    ₹102 Cr
    18.6%
    ₹86 Cr
    22.9%
    ₹70 Cr
    PBT
    ₹715 Cr
    10.5%
    ₹647 Cr
    3.2%
    ₹627 Cr
    39.6%
    ₹449 Cr
    59.8%
    ₹281 Cr
    778.1%
    ₹32 Cr
    50.0%
    ₹64 Cr
    22.9%
    ₹83 Cr
    38.3%
    ₹60 Cr
    77.1%
    ₹262 Cr
    Tax %
    23.0%
    11.5%
    26.0%
    8.3%
    24.0%
    11.1%
    27.0%
    10.0%
    30.0%
    172.7%
    11.0%
    74.4%
    43.0%
    13.2%
    38.0%
    15.6%
    45.0%
    28.6%
    35.0%
    Net Profit
    ₹554 Cr
    15.2%
    ₹481 Cr
    0.6%
    ₹478 Cr
    46.6%
    ₹326 Cr
    66.3%
    ₹196 Cr
    575.9%
    ₹29 Cr
    19.4%
    ₹36 Cr
    29.4%
    ₹51 Cr
    54.5%
    ₹33 Cr
    80.6%
    ₹170 Cr
    EPS (₹)
    20.7
    15.5%
    17.92
    0.6%
    17.81
    46.5%
    12.16
    56.9%
    7.75
    568.1%
    1.16
    21.1%
    1.47
    29.7%
    2.09
    53.7%
    1.36
    96.1%
    35.1
    Div Payout
    2.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
    Liabilities
    Equity Capital
    ₹54 Cr
    0.0%
    ₹54 Cr
    0.0%
    ₹54 Cr
    0.0%
    ₹54 Cr
    5.9%
    ₹51 Cr
    2.0%
    ₹50 Cr
    2.0%
    ₹49 Cr
    0.0%
    ₹49 Cr
    2.1%
    ₹48 Cr
    0.0%
    ₹48 Cr
    Reserves
    ₹3.7K Cr
    9.6%
    ₹3.3K Cr
    16.9%
    ₹2.9K Cr
    20.1%
    ₹2.4K Cr
    51.8%
    ₹1.6K Cr
    17.4%
    ₹1.3K Cr
    2.5%
    ₹1.3K Cr
    4.3%
    ₹1.2K Cr
    9.7%
    ₹1.1K Cr
    16.4%
    ₹976 Cr
    Borrowings
    ₹945 Cr
    31.6%
    ₹718 Cr
    10.5%
    ₹802 Cr
    28.5%
    ₹1.1K Cr
    1.2%
    ₹1.1K Cr
    19.1%
    ₹931 Cr
    0.2%
    ₹929 Cr
    18.0%
    ₹787 Cr
    72.6%
    ₹456 Cr
    176.4%
    ₹165 Cr
    Other Liabilities
    ₹757 Cr
    14.4%
    ₹662 Cr
    15.7%
    ₹572 Cr
    4.6%
    ₹547 Cr
    29.9%
    ₹421 Cr
    10.8%
    ₹380 Cr
    2.1%
    ₹388 Cr
    11.8%
    ₹347 Cr
    1.2%
    ₹343 Cr
    16.3%
    ₹295 Cr
    Total Liabilities
    ₹5.4K Cr
    13.5%
    ₹4.8K Cr
    11.4%
    ₹4.3K Cr
    4.5%
    ₹4.1K Cr
    30.2%
    ₹3.1K Cr
    16.8%
    ₹2.7K Cr
    1.1%
    ₹2.7K Cr
    9.7%
    ₹2.4K Cr
    22.5%
    ₹2.0K Cr
    33.6%
    ₹1.5K Cr
    Assets
    Fixed Assets
    ₹3.2K Cr
    27.2%
    ₹2.5K Cr
    12.4%
    ₹2.2K Cr
    9.1%
    ₹2.0K Cr
    15.4%
    ₹1.8K Cr
    9.9%
    ₹1.6K Cr
    5.1%
    ₹1.7K Cr
    42.6%
    ₹1.2K Cr
    9.1%
    ₹1.1K Cr
    19.7%
    ₹914 Cr
    CWIP
    ₹318 Cr
    40.3%
    ₹533 Cr
    37.4%
    ₹388 Cr
    18.7%
    ₹327 Cr
    25.5%
    ₹439 Cr
    5.4%
    ₹464 Cr
    21.5%
    ₹382 Cr
    42.6%
    ₹666 Cr
    110.1%
    ₹317 Cr
    2541.7%
    ₹12 Cr
    Investments
    ₹3 Cr
    0.0%
    ₹3 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    Other Assets
    ₹1.9K Cr
    10.1%
    ₹1.7K Cr
    3.6%
    ₹1.7K Cr
    3.7%
    ₹1.7K Cr
    84.9%
    ₹930 Cr
    51.2%
    ₹615 Cr
    5.9%
    ₹581 Cr
    1.9%
    ₹570 Cr
    0.5%
    ₹573 Cr
    2.5%
    ₹559 Cr
    Total Assets
    ₹5.4K Cr
    13.5%
    ₹4.8K Cr
    11.4%
    ₹4.3K Cr
    4.5%
    ₹4.1K Cr
    30.2%
    ₹3.1K Cr
    16.8%
    ₹2.7K Cr
    1.1%
    ₹2.7K Cr
    9.7%
    ₹2.4K Cr
    22.5%
    ₹2.0K Cr
    33.6%
    ₹1.5K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
    Operating CF
    ₹714 Cr
    14.4%
    ₹624 Cr
    2.0%
    ₹612 Cr
    5.1%
    ₹645 Cr
    107.4%
    ₹311 Cr
    28.5%
    ₹242 Cr
    38.3%
    ₹175 Cr
    5.4%
    ₹166 Cr
    163.5%
    ₹63 Cr
    72.4%
    ₹228 Cr
    Investing CF
    ₹-1.1K Cr
    51.0%
    ₹-721 Cr
    63.5%
    ₹-441 Cr
    28.9%
    ₹-342 Cr
    18.8%
    ₹-421 Cr
    76.2%
    ₹-239 Cr
    174.7%
    ₹-87 Cr
    65.1%
    ₹-249 Cr
    260.9%
    ₹-69 Cr
    71.4%
    ₹-241 Cr
    Financing CF
    ₹272 Cr
    380.4%
    ₹-97 Cr
    81.1%
    ₹-514 Cr
    248.6%
    ₹346 Cr
    116.3%
    ₹160 Cr
    297.5%
    ₹-81 Cr
    8000.0%
    ₹-1 Cr
    101.0%
    ₹97 Cr
    977.8%
    ₹9 Cr
    228.6%
    ₹-7 Cr
    Net Cash Flow
    ₹-103 Cr
    46.9%
    ₹-194 Cr
    43.4%
    ₹-343 Cr
    152.9%
    ₹648 Cr
    1196.0%
    ₹50 Cr
    164.1%
    ₹-78 Cr
    189.7%
    ₹87 Cr
    521.4%
    ₹14 Cr
    366.7%
    ₹3 Cr
    115.0%
    ₹-20 Cr
    Free Cash Flow
    ₹-123 Cr
    211.8%
    ₹110 Cr
    67.2%
    ₹335 Cr
    18.1%
    ₹409 Cr
    976.3%
    ₹38 Cr
    62.0%
    ₹100 Cr
    869.2%
    ₹-13 Cr
    90.2%
    ₹-133 Cr
    64.2%
    ₹-81 Cr
    214.1%
    ₹71 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016
    Debtor Days
    34d
    17.2%
    29d
    20.8%
    24d
    7.7%
    26d
    13.3%
    30d
    11.8%
    34d
    5.6%
    36d
    12.2%
    41d
    0.0%
    41d
    105.0%
    20d
    Inventory Days
    29d
    3.6%
    28d
    12.5%
    32d
    8.6%
    35d
    2.8%
    36d
    14.3%
    42d
    2.3%
    43d
    65.4%
    26d
    0.0%
    26d
    7.1%
    28d
    Days Payable
    89d
    9.9%
    81d
    10.0%
    90d
    21.1%
    114d
    26.7%
    90d
    34.8%
    138d
    6.1%
    147d
    3.5%
    142d
    14.5%
    124d
    34.8%
    92d
    Cash Conv. Cycle
    -26d
    8.3%
    -24d
    29.4%
    -34d
    34.6%
    -52d
    116.7%
    -24d
    61.3%
    -62d
    7.5%
    -67d
    10.7%
    -75d
    33.9%
    -56d
    24.4%
    -45d
    Working Capital Days
    -7d
    66.7%
    -21d
    34.4%
    -32d
    13.5%
    -37d
    85.0%
    -20d
    58.3%
    -48d
    54.8%
    -31d
    72.2%
    -18d
    45.5%
    -33d
    43.5%
    -23d
    ROCE
    17.0%
    15.0%
    20.0%
    0.0%
    20.0%
    17.6%
    17.0%
    13.3%
    15.0%
    200.0%
    5.0%
    16.7%
    6.0%
    0.0%
    6.0%
    —
    —

    Source: Screener.in · Lower days = better efficiency

    Frequently Asked Questions

    What is Global Health Limited share price today?
    Global Health Limited (MEDANTA) is currently trading at ₹1,283 on NSE, up 1.78% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Global Health Limited available in F&O (Futures & Options)?
    Yes, Global Health Limited (MEDANTA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Global Health Limited 52-week high and low?
    Global Health Limited's 52-week high is ₹1,544 and the 52-week low is ₹955. The current price of ₹1,283 is 16.9% below the 52W high.
    What is Global Health Limited P/E ratio?
    Global Health Limited's current P/E ratio is 55.6. This indicates the market is paying ₹55.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Global Health Limited options?
    Global Health Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MEDANTA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.